IM Cannabis Approves 3-for-1 Share Consolidation to Support Nasdaq Compliance
IM Cannabis announced on November 18 that its board had approved combining every three existing common shares into one. The medical-cannabis company, which serves patients in Israel, expects the consolidation to take effect on November 23, with Nasdaq trading on the adjusted basis beginning at the opening that day. The company said the change aims to “increase the per-share trading price” to support compliance with Nasdaq’s US$1 minimum bid-price requirement. Implementation remains subject to Nasdaq’s final confirmation and the completion of corporate, transfer-agent and market processes. Its name and IMCC trading symbol will stay the same. The number of outstanding common shares is expected to fall from 1,844,162 to approximately 614,721, depending on rounding. No fractional shares will be issued: fractions of at least one-half will become a whole share, while smaller fractions will be cancelled. The share numbers and prices attached to convertible or exercisable instruments will be adjusted proportionately under their terms. IM Cannabis previously completed a 30-for-1 share consolidation on August 27, 2026. The company cautioned that this latest consolidation does not guarantee continued Nasdaq compliance or listing. After it takes effect, registered shareholders will receive instructions from Computershare Investor Services Inc. on exchanging their shares. Investors holding through an intermediary do not need to take action to receive their adjusted shares and can direct processing questions to that intermediary.

Commentary